Our Approach

  • Our unique pipeline of cannabinoid therapeutics are the result of advanced research in the space and insights of key industry experts on our team.

  • We prioritize safety alongside efficacy, ensuring therapeutic options that respond to patient needs.

  • We benefit from lower production costs without sacrificing quality. Our efficient processes translate to optimized therapies accessible to patients and payers.

  • We apply a regulatory approval process tailored to our therapeutics, making it faster and more efficient.

  • Our team of experts in cannabinoid science and pharmaceutical development provides invaluable knowledge and guidance.

 

6 DEA Licences

BRC owns a portfolio of 6 DEA Licenses (called ‘Registrations’). All 6 DEA Registrations are for product codes 7360, 7350, and 7370, encompassing the full range of cannabinoid raw materials and manufactured products.

 

Schedule I Researcher

✓

 

Schedule I Analytical

✓

 

Schedule I Distribution

✓

 

Schedule 1 Bulk Manufacturer


(Cultivation and Manufacturing)

✓

 

Schedule I Importer

✓

 

Schedule I Exporter

✓